Abstract
Mycotic aneurysm (MA) is rare but is a serious complication of infective endocarditis (IE). To evaluate the epidemiological, microbiological, diagnostic, therapeutic and prognostic data of patients with this complication. In a French bi-center prospective study of patients who presented in our endocarditis reference centers with a diagnosis of definite IE from 1988 to 2017 ( n = 2483), 101 (4%) presented MA. Patients with MA were younger (56 vs. 67y, P < 0.001), more often male (83% vs. 71%, P = 0.007), intravenous drug users (13% vs. 5%, P < 0.001). Diabetes (5% vs. 15%, P = 0.004), neoplasia (9% vs. 16%, P = 0.049), history of valve replacement (31% vs. 21%, P = 0.031) and cardiac device (5% vs. 20%, P < 0.001) were less frequent in MA group. Positive blood cultures were more frequent in MA group (97% vs. 81%). MA group had more aortic and mitral location (63% vs. 48%, p = 0.006 and 53% vs. 42%, P = 0,034, respectively) with more aortic perforation (25% vs. 14%, P = 0.002). Septic emboli were more frequents in MA group (81% vs. 41%, P < 0.001) regarding cerebral septic emboli (57% vs. 17%, P < 0.001), non-cerebral emboli (39% vs. 22%, p < 0.001) and multiple septic emboli (25% vs. 8%, P < 0.001). MA group had more cerebral events: ischemic stroke (33% vs. 12%, P < 0.001), intracranial hemorrhage (33% vs. 3%, P < 0.001). The indication of cardiac surgery was more frequent in the MA group (83% vs. 70%, P = 0.007) but the delay to surgery was longer (20 vs. 13 days, P = 0.029). Regarding the evolution, MA group had higher in-hospital mortality (22% vs. 13%, p0.014) and poorer 1-month survival (65% vs. 80%, P = 0.045) but the one-year mortality did not differ (52% vs. 49%, P = 0.79). Our data highlight that MA in IE is associated with poor short-term prognosis, mainly due to neurological complications in his younger population. One of the future challenges should be the improvement of the diagnostic of MA in IE.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.